Page last updated: 2024-08-23

epirubicin and Esophagitis

epirubicin has been researched along with Esophagitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, XJ; Li, LY; Wang, MZ; Xia, Y; Zhang, L; Zhang, XT; Zhao, J; Zhong, W	1
Campbell, C; Videtic, GM; Vincent, MD	1
Bracarda, S; Crinò, L; Darwish, S; de Angelis, V; de Marinis, F; Latini, P; Maranzano, E; Meacci, L; Minotti, V; Panizza, BM; Piro, F; Tonato, M	1

Trials

1 trial(s) available for epirubicin and Esophagitis

Article	Year
Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival; Treatment Outcome; Vincristine	2002

Article

Year

Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer.

Lung cancer (Amsterdam, Netherlands), 2002, Volume: 37, Issue:1

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Esophagitis; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival; Treatment Outcome; Vincristine

2002

Other Studies

2 other study(ies) available for epirubicin and Esophagitis

Article	Year
[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate	2012
Primary chemoradiation as definitive treatment for unresectable cancer of the trachea. Canadian respiratory journal, 2003, Volume: 10, Issue:3 Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Diarrhea; Drug Administration Schedule; Epirubicin; Esophagitis; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Peripheral Nervous System Diseases; Radiography, Thoracic; Radiotherapy Dosage; Tracheal Neoplasms; Treatment Outcome; Venous Thrombosis	2003

Article

Year

[Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Myelopoiesis; Radiation Pneumonitis; Radiotherapy, Conformal; Remission Induction; Small Cell Lung Carcinoma; Survival Rate

2012

Primary chemoradiation as definitive treatment for unresectable cancer of the trachea.

Canadian respiratory journal, 2003, Volume: 10, Issue:3

Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Diarrhea; Drug Administration Schedule; Epirubicin; Esophagitis; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Peripheral Nervous System Diseases; Radiography, Thoracic; Radiotherapy Dosage; Tracheal Neoplasms; Treatment Outcome; Venous Thrombosis

2003